Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refractory central nervous s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Brain Stem Glioma
• Ependymoma
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Medulloblastoma
• Oligodendroglioma

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Brain Stem Glioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-02-06